Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 2
2005 3
2006 2
2007 4
2008 1
2009 7
2010 2
2011 6
2012 7
2013 12
2014 14
2015 13
2016 17
2017 22
2018 13
2019 9
2020 12
2021 9
2022 4
2023 19
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

162 results

Results by year

Filters applied: . Clear all
Page 1
Tumor-targeted dual-action NSAID-platinum(iv) anticancer prodrugs.
Kastner A, Mendrina T, Bachmann F, Berger W, Keppler BK, Heffeter P, Kowol CR. Kastner A, et al. Among authors: heffeter p. Inorg Chem Front. 2023 Jun 28;10(14):4126-4138. doi: 10.1039/d3qi00968h. eCollection 2023 Jul 11. Inorg Chem Front. 2023. PMID: 37440920 Free PMC article.
Metal Drugs and the Anticancer Immune Response.
Englinger B, Pirker C, Heffeter P, Terenzi A, Kowol CR, Keppler BK, Berger W. Englinger B, et al. Among authors: heffeter p. Chem Rev. 2019 Jan 23;119(2):1519-1624. doi: 10.1021/acs.chemrev.8b00396. Epub 2018 Nov 29. Chem Rev. 2019. PMID: 30489072 Review.
Thiosemicarbazone Derivatives Developed to Overcome COTI-2 Resistance.
Pósa V, Stefanelli A, Nunes JHB, Hager S, Mathuber M, May NV, Berger W, Keppler BK, Kowol CR, Enyedy ÉA, Heffeter P. Pósa V, et al. Among authors: heffeter p. Cancers (Basel). 2022 Sep 14;14(18):4455. doi: 10.3390/cancers14184455. Cancers (Basel). 2022. PMID: 36139615 Free PMC article.
Einbau von (Bioaktiven) Äquatorialen Liganden in Platin(IV)-Komplexe.
Kastner A, Schueffl H, Yassemipour PA, Keppler BK, Heffeter P, Kowol CR. Kastner A, et al. Among authors: heffeter p. Angew Chem Weinheim Bergstr Ger. 2023 Nov 13;135(46):e202311468. doi: 10.1002/ange.202311468. Epub 2023 Oct 13. Angew Chem Weinheim Bergstr Ger. 2023. PMID: 38516539 Free PMC article.
The calcium-sensing receptor modulates the prostaglandin E2 pathway in intestinal inflammation.
Gushchina V, Kupper N, Schwarzkopf M, Frisch G, Piatek K, Aigner C, Michel A, Schueffl H, Iamartino L, Elajnaf T, Manhardt T, Vlasaty A, Heffeter P, Bassetto M, Kállay E, Schepelmann M. Gushchina V, et al. Among authors: heffeter p. Front Pharmacol. 2023 Apr 20;14:1151144. doi: 10.3389/fphar.2023.1151144. eCollection 2023. Front Pharmacol. 2023. PMID: 37153788 Free PMC article.
Anticancer activity of metal complexes: involvement of redox processes.
Jungwirth U, Kowol CR, Keppler BK, Hartinger CG, Berger W, Heffeter P. Jungwirth U, et al. Among authors: heffeter p. Antioxid Redox Signal. 2011 Aug 15;15(4):1085-127. doi: 10.1089/ars.2010.3663. Epub 2011 May 11. Antioxid Redox Signal. 2011. PMID: 21275772 Free PMC article. Review.
Carboplatin-induced upregulation of pan β-tubulin and class III β-tubulin is implicated in acquired resistance and cross-resistance of ovarian cancer.
Pernar Kovač M, Tadić V, Kralj J, Duran GE, Stefanelli A, Stupin Polančec D, Dabelić S, Bačić N, Tomicic MT, Heffeter P, Sikic BI, Brozovic A. Pernar Kovač M, et al. Among authors: heffeter p. Cell Mol Life Sci. 2023 Sep 17;80(10):294. doi: 10.1007/s00018-023-04943-0. Cell Mol Life Sci. 2023. PMID: 37718345 Free PMC article.
162 results